BTG plc (LON:BTG)‘s stock had its “buy” rating restated by stock analysts at Numis Securities Ltd in a note issued to investors on Wednesday, August 9th, Marketbeat.com reports. They currently have a GBX 900 ($11.68) price objective on the stock. Numis Securities Ltd’s target price would indicate a potential upside of 35.54% from the company’s previous close.
Several other research analysts also recently commented on BTG. Panmure Gordon reaffirmed a “buy” rating and issued a GBX 737 ($9.57) price objective on shares of BTG plc in a report on Thursday, April 20th. Peel Hunt reiterated a “hold” rating and issued a GBX 630 ($8.18) target price on shares of BTG plc in a research note on Tuesday, May 16th. Jefferies Group LLC restated a “buy” rating and set a GBX 775 ($10.06) price objective on shares of BTG plc in a research report on Tuesday, May 16th. J P Morgan Chase & Co lowered their price objective on shares of BTG plc from GBX 790 ($10.26) to GBX 750 ($9.74) and set a “neutral” rating on the stock in a research report on Wednesday, May 17th. Finally, Deutsche Bank AG restated a “buy” rating and set a GBX 775 ($10.06) price objective on shares of BTG plc in a research report on Thursday, May 18th. Three investment analysts have rated the stock with a hold rating and six have issued a buy rating to the stock. The stock currently has a consensus rating of “Buy” and a consensus price target of GBX 766.44 ($9.95).
Shares of BTG plc (LON:BTG) opened at 664.00 on Wednesday. BTG plc has a 52 week low of GBX 528.36 and a 52 week high of GBX 738.50. The firm’s 50-day moving average price is GBX 665.26 and its 200 day moving average price is GBX 634.02. The company’s market cap is GBX 2.56 billion.
TRADEMARK VIOLATION WARNING: This article was originally published by BNB Daily and is the property of of BNB Daily. If you are viewing this article on another publication, it was illegally copied and reposted in violation of United States and international copyright & trademark laws. The original version of this article can be read at https://www.baseball-news-blog.com/2017/08/19/btg-plc-lonbtg-receives-buy-rating-from-numis-securities-ltd-updated.html.
In other BTG plc news, insider Rolf Soderstrom sold 22,624 shares of BTG plc stock in a transaction dated Friday, June 9th. The shares were sold at an average price of GBX 649 ($8.43), for a total value of £146,829.76 ($190,613.73).
About BTG plc
BTG plc is engaged in the business of healthcare, focusing on Interventional Medicine therapies for liver cancer, emphysema and vascular disorders, specialty pharmaceuticals for acute care uses, and a licensing business. The Company operates through three segments: Interventional Medicine, Specialty Pharmaceuticals and Licensing.
Receive News & Ratings for BTG plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BTG plc and related companies with MarketBeat.com's FREE daily email newsletter.